Grown Rogue International (GRUSF) Free Cash Flow (QoQ) (2013 - 2026)
Grown Rogue International (GRUSF) Free Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -221.84% |
| Sep 30, 2025 | 136,546,360.61% |
| Jun 30, 2025 | 216.05% |
| Mar 31, 2025 | -144.06% |
| Dec 31, 2024 | 23.53% |
| Sep 30, 2024 | -16.14% |
| Jun 30, 2024 | 46.70% |
| Mar 31, 2024 | 885.96% |
| Apr 30, 2023 | 178.66% |
| Jan 31, 2022 | -100.00% |
| Oct 31, 2021 | 78,062,896.51% |
| Jul 31, 2021 | -165.48% |
| Apr 30, 2021 | 264.89% |
| Jan 31, 2021 | 166.72% |
| Oct 31, 2020 | 58.03% |
| Jul 31, 2020 | -331.61% |
| Apr 30, 2020 | 198.55% |
| Jan 31, 2020 | 102.04% |
| Oct 31, 2019 | -228.82% |